Mandibular metastasis presenting as the initial maifestation of malignant pheochromocytoma

European Journal of Radiology

Volumn 44, Issue 1, 2002, Pages 5-9

  Yanagi, Yoshinobu ^a   Asaumi, Jun ichi ^a   Hisatomi, Miki ^a   Konouchi, Hironobu ^a   Wakasa, Toru ^a   Kishi, Kanji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Malignant pheochromocytoma; Mandible; Metastasis

Indexed keywords

BIOPSY; CALCIFICATION (BIOCHEMISTRY); COMPUTERIZED TOMOGRAPHY; MAGNETIC RESONANCE IMAGING; METABOLITES; TUMORS;

MANDIBULAR METASTASIS;

RADIOLOGY;

(3 IODOBENZYL)GUANIDINE; CATECHOLAMINE; IODINE 131;

ADRENAL GLAND; ADULT; ARTERY; ARTICLE; BIOPSY; BLOOD VESSEL; BONE METASTASIS; CALCIFICATION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOCRINE SYSTEM; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER METASTASIS; LUMBAR VERTEBRA; MALE; MANDIBLE; MASS; METABOLITE; METASTASIS; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIOSTEUM; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RADIOGRAPHY; SACROILIAC JOINT; SCINTIGRAPHY; SPINE METASTASIS;

ADRENAL GLAND NEOPLASMS; BIOPSY; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MANDIBLE; MANDIBULAR NEOPLASMS; MIDDLE AGED; NUCLEAR PROTEINS; PHEOCHROMOCYTOMA;

EID: 0036804469     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(01)00366-7     Document Type: Article

References (17)

1. Noshiro T., Shimizu K., Watanabe T., et al. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Am. J. Hypertens. 13:2000;35-43.
2. John H., Ziegler W.H., Hauri D., Jaeger P. Pheochromocytomas: can malignant potential be predicted? Urology. 53:1999;679-683.
3. Lynn M.D., Braunstein E.M., Wahl R.L., Shapiro B., Gross M.D., Rabbani R. Bone metastases in pheochromocytoma: comparative studies of efficacy of imaging. Radiology. 160:1986;701-706.
4. Brown H.M., Komorowski R.A., Wilson S.D., Demeure M.J., Zhu Y.R. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: a positive correlation between MIB-1 staining and malignant tumor behavior. Cancer. 86:1999;1583-1589.
5. Nativ O., Grant C.S., Sheps S.G., et al. The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma. Cancer. 69:1992;2683-2687.
6. Boraschi P., Braccini G., Grassi L., et al. Incidentally discovered adrenal masses: evaluation with gadolinium enhancement and fat-suppressed MR imaging at 0.5 T. Eur. J. Radiol. 24:1997;245-252.
7. Oishi S., Sasaki M., Sato T. Elevated immunoreactive endothelin levels in patients with pheochromocytoma. Am. J. Hypertens. 7:1994;717-722.
8. Fields R.T. Jr, Byrd D.L., Preskitt J.T. Malignant pheochromocytoma with mandibular metastasis. J. Oral Maxillofac. Surg. 56:1998;979-984.
9. Vasen H.F., van der Feltz M., Raue F., Kruseman A.N., Koppeschaar H.P., Pieters G., Seif F.J., Blum W.F., Lips C.J. The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. Arch. Intern. Med. 152:1992;1250-1252.
10. Yamamoto Y., Isobe Y., Nishiyama Y., Takashima H., Ohkawa M., Kihara M., Matsusaka K., Miyauchi A., Kobayashi S., Tanabe M. Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B. Clin. Nucl. Med. 23:1998;13-15.
11. Akama H., Noshiro T., Kimura N., Shimizu K., Watanabe T., Shibukawa S., Nakai S., Miura W., Ito S., Miura Y. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma andpheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene. Intern. Med. 38:1999;145-149.
12. Chen M.Y., Chew E.Y., Reynolds J.C., Chao D.L., Oldfield E.H. Metastatic brainstem pheochromocytoma in a patient with von Hippel-Lindau disease. Case illustration. J. Neurosurg. 94:2001;138.
13. Yanagi Y, Kishi K. Dynamic MRI in oral and maxillofacial region. Jpn J Med Imaging, Feb. 11-13, 1999, Tokyo.
14. Shapiro B., Copp J.E., Sisson J.C., Eyre P.L., Wallis J., Beierwaltes W.H. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J. Nucl. Med. 26:1985;576-585.
15. Shulkin B.L., Koeppe R.A., Francis I.R., Deeb G.M., Lloyd R.V., Thompson N.W. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology. 186:1993;711-715.
16. Shulkin B.L., Thompson N.W., Shapiro B., Francis I.R., Sisson J.C. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology. 212:1999;35-41.
17. Von Moll L., McEwan A.J., Shapiro B., Sisson J.C., Gross M.D., Lloyd R., Beals E., Beierwaltes W.H., Thompson N.W. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J. Nucl. Med. 28:1987;979-988.